Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11397 | 30913263 | PLoS One | Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective. | 2019 | Details |
| A11399 | 30912337 | Endocrinol Metab (Seoul) | Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases. | 2019 | Details |
| A11402 | 30912099 | Semin Liver Dis | Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics. | 2019 | Details |
| A11403 | 30909521 | Cells | A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver. | 2019 | Details |
| A11404 | 30908822 | Intern Med J | Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme. | 2019 | Details |
| A11411 | 30905786 | Biochim Biophys Acta Mol Basis Dis | Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation. | 2019 | Details |
| A11412 | 30905785 | Biochim Biophys Acta Mol Basis Dis | Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. | 2019 | Details |
| A11415 | 30903305 | Eur J Pediatr | Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease. | 2019 | Details |
| A11417 | 30902670 | Lancet Gastroenterol Hepatol | Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. | 2019 | Details |
| A11421 | 30901317 | Rom J Intern Med | Non-alcoholic fatty pancreas disease - practices for clinicians. | 2019 | Details |
| A11422 | 30901032 | J Clin Endocrinol Metab | Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11423 | 30901029 | Endocr Rev | Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule. | 2019 | Details |
| A11427 | 30899593 | J Adv Res | Repin1 deficiency in liver tissue alleviates NAFLD progression in mice. | 2018 | Details |
| A11428 | 30898698 | Gene | Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. | 2019 | Details |
| A11429 | 30898592 | Sex Med Rev | Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems. | 2019 | Details |
| A11434 | 30896957 | Rev Esp Enferm Dig | Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? | 2019 | Details |
| A11435 | 30896956 | Rev Esp Enferm Dig | An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. | 2019 | Details |
| A11437 | 30896648 | Medicine (Baltimore) | A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11438 | 30896410 | Asia Pac J Clin Nutr | Utility of different indices in screening Chinese postmenopausal women for hepatic steatosis. | 2019 | Details |
| A11440 | 30894137 | BMC Gastroenterol | The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. | 2019 | Details |
| A11441 | 30893108 | Curr Opin Lipidol | Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell? | 2019 | Details |
| A11442 | 30893090 | Curr Opin Clin Nutr Metab Care | Sarcopenic obesity in fatty liver. | 2019 | Details |
| A11444 | 30892820 | Diabetes Metab Res Rev | Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort. | 2019 | Details |
| A11446 | 30891617 | J Mol Med (Berl) | Innate immune regulatory networks in hepatic lipid metabolism. | 2019 | Details |
| A11447 | 30891575 | Animal Model Exp Med | Obese zebrafish: A small fish for a major human health condition. | 2018 | Details |
| A11449 | 30889997 | Expert Opin Ther Pat | A patent update on cannabinoid receptor 1 antagonists (2015-2018). | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11451 | 30889343 | Rev Med Inst Mex Seguro Soc | Nonalcoholic hepatic steatosis: a silent disease | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11463 | 30885145 | BMC Gastroenterol | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. | 2019 | Details |
| A11464 | 30884843 | Cells | Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. | 2019 | Details |
| A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
| A11470 | 30882489 | AIDS | Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation. | 2019 | Details |
| A11474 | 30881345 | Front Endocrinol (Lausanne) | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. | 2019 | Details |
| A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
| A11485 | 30876959 | Clin Gastroenterol Hepatol | Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. | 2019 | Details |
| A11489 | 30875494 | Atherosclerosis | Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. | 2019 | Details |
| A11490 | 30875479 | Expert Rev Gastroenterol Hepatol | Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. | 2019 | Details |
| A11494 | 30871514 | BMC Complement Altern Med | Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |
| A11496 | 30871368 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? | 2019 | Details |
| A11497 | 30871035 | Nutrients | Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. | 2019 | Details |
| A11498 | 30870854 | Ann Nutr Metab | Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China. | 2019 | Details |
| A11499 | 30870804 | Nutrition | Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11501 | 30868786 | J Ayub Med Coll Abbottabad | Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid. | 2019 | Details |
| A11504 | 30868489 | Curr Med Sci | Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway. | 2019 | Details |
| A11505 | 30868315 | Acta Diabetol | Oral glucose effectiveness and metabolic risk in obese children and adolescents. | 2019 | Details |
| A11515 | 30862999 | World J Gastroenterol | Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. | 2019 | Details |
| A11518 | 30861601 | J Cell Biochem | Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats. | 2019 | Details |
| A11521 | 30860882 | Am J Physiol Endocrinol Metab | Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease. | 2019 | Details |
| A11522 | 30860877 | Am J Physiol Endocrinol Metab | Human Paneth cell α-defensin-5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice. | 2019 | Details |
| A11523 | 30860608 | Lipids | Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats. | 2019 | Details |
| A11526 | 30857678 | Food Chem | Quinoa intake reduces plasma and liver cholesterol, lessens obesity-associated inflammation, and helps to prevent hepatic steatosis in obese db/db mouse. | 2019 | Details |
| A11529 | 30855277 | J Clin Invest | Resolving inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A11534 | 30854350 | Can J Gastroenterol Hepatol | Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. | 2019 | Details |
| A11543 | 30850619 | Sci Rep | Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. | 2019 | Details |
| A11548 | 30848932 | FASEB J | Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3. | 2019 | Details |
| A11549 | 30848827 | J Clin Endocrinol Metab | Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. | 2019 | Details |
| A11551 | 30847736 | Curr Obes Rep | Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. | 2019 | Details |
| A11553 | 30844893 | Curr Opin Gastroenterol | Current treatment options for nonalcoholic fatty liver disease. | 2019 | Details |
| A11555 | 30842494 | Sci Rep | Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. | 2019 | Details |
| A11556 | 30841536 | Int J Mol Sci | mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars. | 2019 | Details |
| A11564 | 30837878 | Front Pharmacol | G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. | 2019 | Details |
| A11567 | 30836637 | Nutrients | Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD. | 2019 | Details |
| A11574 | 30833801 | World J Gastroenterol | Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. | 2019 | Details |
| A11575 | 30833214 | Clin Nutr | Non-alcoholic fatty liver in hereditary fructose intolerance. | 2019 | Details |
| A11576 | 30833154 | Endocrinol Diabetes Nutr (Engl Ed) | Inflammatory stress and altered angiogenesis evoked by very high-fat diets in mouse liver. | 2019 | Details |
| A11577 | 30832745 | Br J Nutr | Dietary determinants of hepatic fat content and insulin resistance in overweight/obese children: a cross-sectional analysis of the Prevention of Diabetes in Kids (PREDIKID) study. | 2019 | Details |
| A11579 | 30832423 | Microorganisms | Microbial Population Changes and Their Relationship with Human Health and Disease. | 2019 | Details |
| A11581 | 30831319 | Cell Mol Gastroenterol Hepatol | Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis. | 2019 | Details |
| A11587 | 30828530 | Adv Sci (Weinh) | Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. | 2018 | Details |
| A11611 | 30820265 | World J Hepatol | Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. | 2019 | Details |
| A11614 | 30819129 | BMC Cancer | Molecular Pathogenesis of Cholangiocarcinoma. | 2019 | Details |
| A11621 | 30815318 | Food Sci Biotechnol | Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease. | 2018 | Details |
| A11623 | 30814508 | Nat Commun | Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. | 2019 | Details |
| A11625 | 30813654 | Nutrients | Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice. | 2019 | Details |
| A11629 | 32461811 | Liver Res | The role of gut microbiota in liver disease development and treatment. | 2019 | Details |
| A11630 | 30811890 | Am J Transplant | OPTN/SRTR 2017 Annual Data Report: Liver. | 2019 | Details |
| A11634 | 30810328 | Rev Esp Enferm Dig | An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. | 2019 | Details |
| A11637 | 30809852 | J Cell Biochem | Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. | 2019 | Details |
| A11640 | 30809151 | Front Physiol | LSEC Fenestrae Are Preserved Despite Pro-inflammatory Phenotype of Liver Sinusoidal Endothelial Cells in Mice on High Fat Diet. | 2019 | Details |
| A11646 | 30806344 | Br J Nutr | Spirulina supplementation in a mouse model of diet-induced liver fibrosis reduced the pro-inflammatory response of splenocytes. | 2019 | Details |
| A11661 | 30799179 | Nutr Metab Cardiovasc Dis | Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK. | 2019 | Details |
| A11663 | 30798598 | J Agric Food Chem | Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. | 2019 | Details |
| A11673 | 30794300 | JAMA Netw Open | Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2019 | Details |
| A11679 | 30792450 | Sci Rep | Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1. | 2019 | Details |
| A11683 | 30791782 | Expert Rev Gastroenterol Hepatol | Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. | 2018 | Details |
| A11684 | 30791778 | Expert Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. | 2018 | Details |
| A11691 | 30789865 | J Pediatr Gastroenterol Nutr | Free-breathing Magnetic Resonance Imaging Assessment of Body Composition in Healthy and Overweight Children: An Observational Study. | 2019 | Details |
| A11695 | 30788772 | J Endocrinol Invest | Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. | 2019 | Details |
| A11697 | 30788048 | World J Diabetes | SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11699 | 30787626 | Diabetes Metab Syndr Obes | Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11717 | 30778334 | Front Endocrinol (Lausanne) | Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health. | 2019 | Details |
| A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11725 | 30775610 | Arch Med Sci Atheroscler Dis | Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study. | 2018 | Details |
| A11736 | 30770929 | Carcinogenesis | MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. | 2020 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |